Annual Cash & Cash Equivalents
$458.40 K
+$283.00 K+161.35%
December 31, 2021
Summary
- As of February 10, 2025, IBER annual cash & cash equivalents is $458.40 thousand, with the most recent change of +$283.00 thousand (+161.35%) on December 31, 2021.
- During the last 3 years, IBER annual cash & cash equivalents has risen by +$283.00 thousand (+161.35%).
Performance
IBER Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4500.00
-$88.50 K-95.16%
September 30, 2022
Summary
- As of February 10, 2025, IBER quarterly cash and cash equivalents is $4500.00, with the most recent change of -$88.50 thousand (-95.16%) on September 30, 2022.
- Over the past year, IBER quarterly cash and cash equivalents has dropped by -$675.90 thousand (-99.34%).
Performance
IBER Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IBER Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +161.3% | -99.3% |
| 3 y3 years | +161.3% | -99.6% |
| 5 y5 years | +161.3% | -99.6% |
IBER Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -99.0% | at low |
| 5 y | 5-year | at high | -61.7% | -99.6% | at low |
| alltime | all time | at high | -61.7% | -99.6% | at low |
Ibere Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $4500.00(-95.2%) |
| Jun 2022 | - | $93.00 K(-31.0%) |
| Mar 2022 | - | $134.80 K(-70.6%) |
| Dec 2021 | $458.40 K | $458.40 K(-32.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $680.40 K(-20.5%) |
| Jun 2021 | - | $855.80 K(-29.7%) |
| Mar 2021 | - | $1.22 M |
| Dec 2020 | $175.40 K | - |
FAQ
- What is Ibere Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Ibere Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Ibere Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of IBER is $458.40 K
What is the all time high annual cash & cash equivalents for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high annual cash & cash equivalents is $458.40 K
What is Ibere Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, IBER annual cash & cash equivalents has changed by +$283.00 K (+161.35%)
What is Ibere Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IBER is $4500.00
What is the all time high quarterly cash and cash equivalents for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high quarterly cash and cash equivalents is $1.22 M
What is Ibere Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, IBER quarterly cash and cash equivalents has changed by -$675.90 K (-99.34%)